Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Sep;20(5):e178-e182.
doi: 10.7861/clinmed.2020-0346. Epub 2020 Jul 21.

Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

Affiliations
Multicenter Study

Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

Eleni E Ladikou et al. Clin Med (Lond). 2020 Sep.

Abstract

Background: COVID-19 infection is characterised, among other features, by a prothrombotic state with high rate of venous thromboembolism (VTE), D-dimer, and fibrinogen levels. Clinical observations have also highlighted that these patients have elevated von Willebrand factor (vWF) and factor VIIIc.

Methods: 24 consecutive COVID-19 positive patients were selected from the intensive care unit (ICU) or the high acuity ward of Brighton and Sussex University Hospitals NHS Trust.

Results: The rate of VTE was 25% and mortality rate was 16.7%. Fibrinogen and D-Dimers were elevated, 7.9 (1.6) g/L and 2.4 (2.02) ug/ml respectively. Factor VIIIc and von vWF antigen levels were both extremely elevated at 279 (148) u/dL and 350 (131) % respectively, which are comparable to levels seen in ICU patients with severe sepsis. vWF levels were significantly higher in patients that died (p=0.017) and showed a positive correlation with age. There was a statistically significant association between COVID-19 disease and non-O blood group (p=0.02); 80% (4/5) of COVID-19 patients with VTE were blood group A.

Conclusion: Very high levels of vWF and factor VIIIc are common in COVID-19 patients, comparable to levels in severely septic non-COVID ICU patients. This could contribute to the hypercoagulable state and increased VTE rate in COVID-19. Further studies are needed to evaluate the use of vWF for stratifying thrombotic risk in COVID-19 and to determine if elevated vWF is contributing to disease pathogenesis.

Keywords: COVID-19; blood group; factor VIIIc; venous thromboembolism; von Willebrand factor.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Schematic representation of how SARS-CoV-2 entry damages the endothelium, which subsequently results in vWF release mediating platelet aggregation and adhesion.
Fig 2.
Fig 2.
Percentage (%) von Willebrand antigen in patients that have passed away or remained alive at the end of the study.
Fig 3.
Fig 3.
Scatter plot of vWF antigen (%) in relation to age in COVID-19 patients.

Comment in

  • Von Willebrand factor.
    Bhogal P, Jensen M, Hart D, Makalanda L, Collins GB, Spooner O, Jaffer O. Bhogal P, et al. Clin Med (Lond). 2020 Nov;20(6):e279. doi: 10.7861/clinmed.Let.20.6.3. Clin Med (Lond). 2020. PMID: 33199342 Free PMC article. No abstract available.

References

    1. Worldometer COVID-19 coronavirus pandemic. www.worldometers.info/coronavirus/.
    1. Yao XH, Li TY, He ZC, et al. [A pathological report of three COVID-19 cases by minimally invasive autopsies]. Zhonghua Bing Li Xue Za Zhi 2020;49:E009. - PubMed
    1. Zhang T, Sun LX, Feng RE. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019]. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:E040. - PubMed
    1. Fox SE, Akmatbekov A, Harbert JL, et al. Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans. MedRxiv 2020;2020.04.06.20050575. - PMC - PubMed
    1. Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982;10:448–50. - PubMed

Publication types

MeSH terms